FORM CIBB-02[See Rule 3(2)]

Manufacturing feasibility assessment

Serial No. 2026-07-30-0111Issued: 30 Jul 2026
1.Product
I want to build exoskeleton for my daughter with Morquio Syndrome so she can walk without wheelchair
2.Submitted by
Anonymous
3.Target market
Global
4.Target retail
$30,000-100,000

5. Verdict

A custom exoskeleton may assist selected Morquio patients but cannot safely promise wheelchair replacement; begin with multidisciplinary spine/orthopedic screening and a supervised feasibility study.

6. Subsystems

  1. 6.1 Patient-specific biomechanics and fitHIGH
  2. 6.2 Powered hip/knee actuationHIGH
  3. 6.3 Spine, fall and overload safetyHIGH
  4. 6.4 Battery and power electronicsMEDIUM
  5. 6.5 Control software and sensingHIGH
  6. 6.6 Custom orthotic interfacesHIGH
  7. 6.7 Clinical evidence and quality systemHIGH

7. Bill of materials

Item1001,00010,000
7.1 Custom carbon-composite orthoses, pads and straps$3,000-$5,000$1,800-$3,000$1,200-$2,000
7.2 Actuators, gearboxes, brakes and transmission$5,000-$8,000$3,000-$5,000$2,000-$3,500
7.3 Structural frame, joints and machined hardware$2,500-$4,500$1,500-$2,700$900-$1,700
7.4 Battery pack, BMS, charger and power electronics$1,200-$2,000$800-$1,400$550-$1,000
7.5 Sensors, controllers, wiring and user controls$1,500-$2,800$900-$1,700$600-$1,100
7.6 Safety hardware, enclosures and emergency release$700-$1,300$450-$850$300-$600
7.7 Assembly, calibration, end-of-line testing and QA$2,000-$3,500$1,200-$2,200$800-$1,500
7.8 Total manufacturing BOM and conversion cost$15,900-$27,100$9,650-$16,850$6,350-$11,400
7.9 TOOLING (one-time)$4 million-$8 million for orthotic sizing fixtures, composite and injection tools, assembly jigs, test rigs and validation builds; clinical and regulatory studies are additional.

At 10,000 units, tooling adds roughly $400-$800 per unit, or 0.4%-2.7% of the $30,000-$100,000 retail range. At 1,000 units it adds $4,000-$8,000 per unit; volume is doing the heavy lifting.

8. Gates to clear

  1. 8.1 [DFM]

    Child-specific anatomy and growth collide with scalable production: a one-size frame is how fit, skin pressure and alignment go sideways.

    Path: Use a modular frame with adjustable links and 3D-scanned custom orthotic interfaces; qualify orthotics labs, then validate sizing through pilot builds and gait-lab fitting.

  2. 8.2 [Certification]

    A powered device claiming to help children with Morquio Syndrome walk needs clinical safety evidence, not vibes and a polished demo video.

    Path: Run ISO 13485 and ISO 14971 design controls; pursue FDA pre-submission then the appropriate US pathway, and EU MDR CE marking via a notified body, supported by IEC 60601, IEC 62304, ISO 10993 and clinical investigation planning.

  3. 8.3 [Tooling]

    Custom fit, expensive actuators and low pediatric volumes can eat the $30,000 floor retail margin for breakfast.

    Path: Start with clinician-fitted pilot units, standardize actuators and electronics, outsource composite orthoses, and fund hard tooling only after demand supports a 1,000-plus unit platform forecast.

9. Prototype sequence

  1. 9.1Form a pediatric rehabilitation team including a pediatric orthopedist, physiatrist, gait lab, orthotist and Morquio specialist.Spinal stability, joint loading and candidacy must be defined before any powered frame touches a child.
  2. 9.2Build a non-powered adjustable fit and alignment mock-up with custom orthotic interfaces.It exposes pressure, range-of-motion and donning problems cheaply, before motors add force and consequences.
  3. 9.3Develop a tethered, torque-limited laboratory prototype with emergency stop, passive supports and instrumented gait testing.Tethered testing allows conservative validation of alignment, loads and control behavior under clinical supervision.
  4. 9.4Complete formal hazard analysis, verification testing and a small ethics-approved supervised feasibility study.This creates the safety and usability evidence needed to choose the FDA and EU MDR regulatory routes.
  5. 9.5Freeze a modular design, qualify contract manufacturers and run a controlled clinical pilot production batch.The pilot converts a bespoke research device into a manufacturable, traceable medical-device platform.

Assessment criteria: J. Tanikella · Engine: GPT-5.6 Terra.

This is a system generated assessment issued on the basis of the information furnished above. It is produced by an automated model and may be incomplete, inaccurate, or fabricated. It is not a substitute for a DFM review by a manufacturer, nor for independent engineering, legal, or manufacturing due diligence.